This document is about allergic rhinitis, which is an inflammatory disorder of the lining inside the nose caused by an allergic reaction to pollen, dust mites, mould, or dander from certain animals. The document provides information on how to diagnose and treat allergic rhinitis.
This pocket guide provides clinicians with a concise framework for diagnosing and managing allergic rhinitis (AR) based on international guidelines. It covers patient assessment, symptom classification, treatment options including pharmacotherapy and allergen immunotherapy, and follow-up strategies. The guide emphasizes the use of the visual analogue scale (VAS) to assess symptom severity and includes recommendations for both controlled and uncontrolled AR cases.
It also addresses comorbid asthma, patient education, and treatment adherence, with specific guidance on medication selection and add-on therapies for symptom management.
Allergic rhinitis (AR) is an inflammatory disorder of the lining inside the nose caused by an allergic reaction to pollen, dust mites, mould, or dander from certain animals.
If the patient answers YES to any of these questions: Have you had an episode or recurrent episodes of wheezing? Do you have troublesome cough, especially at night/during awakening/exercise? Do you cough or wheeze after exercise? Do you experience extended common cold/laryngitis/bronchitis? Does your chest feel tight or do you feel impaired breathing out?
Ask your patient to mark on the horizontal line of 10 cm how bothersome his/her symptoms are. The ends of the horizontal line are defined as the extreme limits of the burden of disease.
Efficacy varies between specific products, only treatment with disease modifying capacity, reduces nasal and/or ocular symptoms, enhances quality of life, lowers need for intake of other anti-allergic medication, induces immunological tolerance, providing sustained clinical benefit, has the potential to prevent asthma.